ABSTRACT: INTRODUCTION: Ranitidine hydrochloride (Zantac(R)), a histamine-2-receptor antagonist, is a widely used medication with an excellent safety record. Anaphylactic reaction to ranitidine is an extremely rare event and a related death has never been described in the literature. CASE PRESENTATION: We present the clinical history, histological and toxicological data of a 51-year-old man with negative anamnesis for allergic events, who died suddenly after the intravenous administration of one phial of Zantac(R) 50 mg prescribed as a routine post-surgical prophylaxis for stress ulcer. CONCLUSION: Although the incidence of anaphylactic reactions related to ranitidine is low, caution needs to be exercised on administration of this drug. In addition, further study is needed to define strategies for the prevention of adverse drug reactions in hospitalized patients.
Lingua originaleEnglish
pagine (da-a)230-232
Numero di pagine3
RivistaJournal of Medical Case Reports
Stato di pubblicazionePubblicato - 2008


  • death
  • ranitidine


Entra nei temi di ricerca di 'Fatal injection of ranitidine: a case report'. Insieme formano una fingerprint unica.

Cita questo